Literature DB >> 22048047

Correlation of N-terminal fragment of B-type natriuretic peptide levels with clinical, laboratory, and echocardiographic abnormalities in children with sickle cell disease.

Shinichi Takatsuki1, David Dunbar Ivy, Rachelle Nuss.   

Abstract

OBJECTIVE: To determine whether the N-terminal fragment of B-type natriuretic peptide (NTproBNP) was a biomarker of clinical, laboratory, and echocardiographic abnormalities in children with homozygous sickle cell disease. STUDY
DESIGN: We conducted a single-center retrospective study that consisted of analysis of data from November 2007 to December 2010. We correlated serum NTproBNP with clinical and laboratory findings, echocardiographic data, and New York Heart Association (NYHA) functional class.
RESULTS: NTproBNP levels from 42 children (median age, 9 years; 52% female) had significant correlations with hemoglobin (r = -0.63, P < .05), and echocardiographic measurements including tricuspid regurgitant velocity (r = 0.46, P < .05), lateral E' (r = -0.52, P < .05), and lateral E/E' ratio (r = 0.60, P < .05), suggesting diastolic dysfunction. In addition, NTproBNP levels increased from NYHA functional class I to class III and had a significant linear correlation with the NYHA functional class (r = 0.69, P < .05).
CONCLUSIONS: NTproBNP correlated with low hemoglobin and tissue Doppler data as indicators of diastolic dysfunction. Elevated NTproBNP may be a prognostic biomarker for the presence of diastolic dysfunction related to anemia in children with sickle cell disease. Copyright Â
© 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22048047      PMCID: PMC3274616          DOI: 10.1016/j.jpeds.2011.09.015

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  30 in total

1.  Deconvolution analysis of cardiac natriuretic peptides during acute volume overload.

Authors:  C J Pemberton; M L Johnson; T G Yandle; E A Espiner
Journal:  Hypertension       Date:  2000-09       Impact factor: 10.190

2.  Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study.

Authors:  S R Ommen; R A Nishimura; C P Appleton; F A Miller; J K Oh; M M Redfield; A J Tajik
Journal:  Circulation       Date:  2000-10-10       Impact factor: 29.690

3.  N-terminal proBNP and mortality in hospitalised patients with heart failure and preserved vs. reduced systolic function: data from the prospective Copenhagen Hospital Heart Failure Study (CHHF).

Authors:  V Kirk; M Bay; J Parner; K Krogsgaard; T M Herzog; S Boesgaard; C Hassager; O W Nielsen; J Aldershvile; H Nielsen
Journal:  Eur J Heart Fail       Date:  2004-03-15       Impact factor: 15.534

4.  Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group.

Authors:  A M Richards; R Doughty; M G Nicholls; S MacMahon; N Sharpe; J Murphy; E A Espiner; C Frampton; T G Yandle
Journal:  J Am Coll Cardiol       Date:  2001-06-01       Impact factor: 24.094

Review 5.  The importance of anemia and its correction in the management of severe congestive heart failure.

Authors:  Donald S Silverberg; Dov Wexler; Adrian Iaina
Journal:  Eur J Heart Fail       Date:  2002-12       Impact factor: 15.534

6.  NT-proBNP as a marker of cardiopulmonary status in sickle cell anaemia in Africa.

Authors:  Zakari Y Aliyu; Aisha Suleiman; Ester Attah; Aisha I Mamman; Aliyu Babadoko; Mehdi Nouraie; Laurel Mendelsohn; Gregory J Kato; Victor R Gordeuk; Mark T Gladwin
Journal:  Br J Haematol       Date:  2010-04-16       Impact factor: 6.998

7.  Clinical significance of brain natriuretic peptide in primary pulmonary hypertension.

Authors:  Hanno H Leuchte; Michael Holzapfel; Rainer A Baumgartner; Isabelle Ding; Claus Neurohr; Michael Vogeser; Tilman Kolbe; Martin Schwaiblmair; Jürgen Behr
Journal:  J Am Coll Cardiol       Date:  2004-03-03       Impact factor: 24.094

8.  Plasma natriuretic peptide levels and the risk of cardiovascular events and death.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Emelia J Benjamin; Eric P Leip; Torbjorn Omland; Philip A Wolf; Ramachandran S Vasan
Journal:  N Engl J Med       Date:  2004-02-12       Impact factor: 91.245

9.  Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival.

Authors:  Oswaldo Castro; Mohammed Hoque; Bernice D Brown
Journal:  Blood       Date:  2002-10-03       Impact factor: 22.113

10.  Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.

Authors:  Mark T Gladwin; Vandana Sachdev; Maria L Jison; Yukitaka Shizukuda; Jonathan F Plehn; Karin Minter; Bernice Brown; Wynona A Coles; James S Nichols; Inez Ernst; Lori A Hunter; William C Blackwelder; Alan N Schechter; Griffin P Rodgers; Oswaldo Castro; Frederick P Ognibene
Journal:  N Engl J Med       Date:  2004-02-26       Impact factor: 91.245

View more
  4 in total

1.  Association between diffuse myocardial fibrosis and diastolic dysfunction in sickle cell anemia.

Authors:  Omar Niss; Robert Fleck; Fowe Makue; Tarek Alsaied; Payal Desai; Jeffrey A Towbin; Punam Malik; Michael D Taylor; Charles T Quinn
Journal:  Blood       Date:  2017-05-15       Impact factor: 22.113

2.  Tricuspid regurgitation velocity and other biomarkers of mortality in children, adolescents and young adults with sickle cell disease in the United States: The PUSH study.

Authors:  Mehdi Nouraie; Deepika S Darbari; Sohail Rana; Caterina P Minniti; Oswaldo L Castro; Lori Luchtman-Jones; Craig Sable; Niti Dham; Gregory J Kato; Mark T Gladwin; Gregory Ensing; Manuel Arteta; Andrew Campbell; James G Taylor; Sergei Nekhai; Victor R Gordeuk
Journal:  Am J Hematol       Date:  2020-04-21       Impact factor: 10.047

Review 3.  Current challenges in pediatric pulmonary hypertension.

Authors:  Shinichi Takatsuki; David Dunbar Ivy
Journal:  Semin Respir Crit Care Med       Date:  2013-09-13       Impact factor: 3.119

4.  Sickle-cell Anemia and Latent Diastolic Dysfunction: Echocardiographic Alterations.

Authors:  André Fattori; Daniela Camargo Oliveira; Roger Frigério Castilho; Otávio Rizzi Coelho
Journal:  Arq Bras Cardiol       Date:  2015-04-01       Impact factor: 2.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.